Медицинская литература. Новинки

 

 

 

 

 

 

НАРУШЕНИЕ ФУНКЦИИ ЩИТОВИДНОЙ ЖЕЛЕЗЫ У ПАЦИЕНТОВ ПОСЛЕ ЛЕЧЕНИЯ ЛИМФОМЫ ХОДЖКИНА

Вы можете загрузить полный текст статьи в формате pdf

Ключевые слова:

Литература:
1. Wettergren L., Björkholm M., Langius$Eklöf A. Validation of an
extended version of the seiqoldw in a cohort of hodgkin lymphoma'
survivors. Quality of life Research. 2005; 14 (10): 2329–2333.
2. Krieger N., Strong E., Makosky C., Weuve J. Breast cancer, birth
cohorts, and Epstein–Barr virus: methodological issues in exploring the ‘hygiene hypothesis’ in relation to breast cancer, Hodgkins
disease, and stomach cancer. Cancer Epidemiol. Biomark. Prev.
2003; 12: 405–411.
3. Aleman B.M., Raemaekers J.M., Tirelli U. et al. Involved-field
radiotherapy for advanced Hodgkin's lymphoma. N. Engl. J. Med.
2003; 348: 2396–2406.
4. Лимфома Ходжкина. Под ред. В.П. Харченко. М.: Русское
слово, 2009.
5. Schimpff S., Diggs C., Wiswell J. et al. Radiation-related thyroid
dysfunction: implications for the treatment of Hodgkin's disease.
Pediatr. Blood Cancer. 2011; 57: 166–168.
6. Robison L., Bhatia S., Ramsay N. et al. Thyroid abnormalities after
therapy for Hodgkin’s disease in childhood. The Oncologist. 1996;
1 (1): 62–67.
7. Hancock S., Cox R., McDougall I. Thyroid diseases after treatment
of Hodgkin's disease. N. Engl. J. Med. 1991; 325: 599–605.
8. Demirkaya M., Sevinir B., Saglam H. et al. Thyroid functions in
longterm survivors of pediatric Hodgkin’s lymphoma treated with
chemotherapy and radiotherapy. J. Clin. Res. Pediatr. Endocrinol.
2011; 3: 89–94.
9. Sklar C., Whitton J., Mertens A. et al. Abnormalities of the thyroid
in survivors of Hodgkin’s disease: data from the Childhood Cancer
Survivor Study. J. Clin. Endocrinol. Metab. 2000; 85: 3227–3232.
10. Acharya S., Sarafoglou K., LaQuaglia M. et al. Thyroid neoplasms
after therapeutic radiation for malignancies during childhood or
adolescence. Cancer. 2003; 97: 2397–2403.
11. Shafford E., Kingston J., Healy J. et al. Thyroid nodular disease
after radiotherapy to the neck for childhood Hodgkin's disease. Br.
J. Cancer. 1999; 80: 808–814.
12. Hunger S., Link M., Donaldson S. ABVD/MOPP and low-dose
involvedfield radiotherapy in pediatric Hodgkin's disease: the
Stanford experience. J. Clin. Oncol. 1994; 12: 2160–2166.
13. Nair N., Advani S. Follow up of alterations in thyroid hormones
and thyrotropin in patients of Hodgkin's diseasegiven mantle radiation. J. Assoc. Physicians. India. 1990; 38: 623–624.
14. Moryl$Bujakowska A., Balwierz W., Sztefko K. Preliminary results
of thyroid function assessment in children and adolescents with
Hodgkin's disease treated according to PGP-HD-97 protocol.
Przegl. Lek. 2004; 61: 81–84.
15. Constine L., Donaldson S., McDougall I. et al. Thyroid dysfunction
after radiotherapy in children with Hodgkin's disease. Cancer.
1984; 53: 878–883.
16. Lin H.M., Teitell M.A. Second malignancy after treatment of pediatric Hodgkin disease. Pediatr. Hematol. Oncol. 2005; 27: 28–36.
17. Bhatia S., Yasui Y., Robison L. et al. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's
disease: report from the Late Effects Study Group. J. Clin. Oncol.
2003; 21: 4386–4394.
18. Constine L.S., Tarbell N., Hudson M.M. et al. Subsequent malignancies in children treated for Hodgkin's disease: associations with
gender and radiation dose. Int. J. Radiat. Oncol. Biol. Phys. 2008;
72: 24–33.
19. Capra M., Hewitt M., Radford M. et al. Children's Cancer and
Leukaemia Group. Longterm outcome in children with
Hodgkin's lymphoma: the United Kingdom Children's Cancer
Study Group HD82 trial. Eur. J. Cancer. 2007; 43: 1171–1179.
20. Metzger M.L., Howard S.C., Hudson M.M. et al. Natural history of
thyroid nodules in survivors of pediatric Hodgkin lymphoma.
Pediatr. Blood Cancer. 2006; 46: 314–319.
21. Brabant G., Toogood A., Shalet S. et al. Hypothyroidism following
childhood cancer therapy – an under diagnosed complication. Int.
J. Cancer. 2012; 130: 1145–1150.
22. Vogelius I.R., Bentzen S.M., Maraldo M.V. et al. Risk factors for
radiationinduced hypothyroidism: a literature-based meta-analysis. Cancer. 2011; 117: 5250–5260.
23. Харченко В.П., Сотников В.М., Щербенко О.И. и др. Возрастные аспекты радиочувствительности щитовидной железы
у больных лимфогранулематозом. Пробл. эндокринол. 1998;
2: 19–21.
24. Metzger M.L., Hudson M.M., Somes G.W. et al. White race as a risk
factor for hypothyroidism after treatment for pediatric Hodgkin's
lymphoma. J. Clin. Oncol. 2006; 24: 1516–1521.
25. Балашов А.Т., Мясников A.A. Заболевания щитовидной железы при комплексном лечении лимфогранулематоза. Эндокринология. 1998; 4: 18.
26. Devney R.B., Sklar C.A., Nesbit M.E. et al. Serial thyroid function
measurements in children with Hodgkin disease. J. Pediatr. 1984;
105: 223–227.
27. Green E.M., Grecher M.L., Yakar D. et al. Thyroid function in
pediatric patients after neck irradiation for Hodgkin’s disease.
Med. Pediatr. Oncol. 1980; 8: 127–136.
28. Glatstein E., McHardy$Young S., Brast N. et al. Alterations in serum
thyrotropin and thyroid function following radiotherapy in patients
with malignant lymphoma. J. Clin. Endocrinol. Metab. 1971; 32:
833–884.
29. Shalet S.M., Rosenstock J.D., Beardwell C.G. et al. Thyroid dysfunction after external irradiation to the neck for Hodgkin’s disease
in childhood. Clin. Radiol. 1977; 28: 511–515.
30. Smith R.E., Adler A.R., Clark P. et al. Thyroid function after mantle irradiation in Hodgkin’s disease. JAMA. 1981; 245: 46.
31. Nelson D.F., Reddy K.V., O’Mara R.E. et al. Thyroid abnormalities
following neck irradiation for Hodgkin’s disease. Cancer. 1978; 42:
2553–2562.
32. Smith R.E., Adler A.R., Clark P. et al. Thyroid function after mantle irradiation in Hodgkin’s disease. JAMA. 1981; 245: 46–49.
33. Massimino M., Gandola L., Pignoli E. et al. TSH suppression as a
possible means of protection against hypothyroidism after irradiation for childhood Hodgkins lymphoma. Pediatr. Blood Cancer.
2011; 57: 166–168.
34. Li Y.Q., Chen P., Haimovitz$Friedman A. et al. Endotelian apoptosis initiates acute bloodbrain barrier disruptions after ionizing
radiation. Cancer Res. 2003; 63: 5950–5956.
35. Roedmann H.P., Blaese M.A. Responses of normal cells to ionizing
radiation. Semin Radiat. Oncol. 2007; 17: 81–88.
36. Nishiyama K., Kozuka T., Higashihara T. et al. Acute radiation thyroiditis. Int. J. Radiat. Oncol. Biol. Phys. 1996; 36: 1221–1224.

Thyroid function after therapy for Hodgkin's disease

Keywords: